consumerism

Despite continued economic impacts from the Covid-19 pandemic, biotechnology companies and VC firms raised significant amounts of funding this week. For example, Massachusetts-based Pandion Therapeutics closed $80 million in funding to develop a therapeutic designed to treat autoimmune diseases.

LEAVE A REPLY

Please enter your comment!
Please enter your name here